Reducing Bacterial Adhesion And Biofouling On Medical Device Surfaces: An Interview With Jeannette Ho

The Endexo® surface modification technology has been extensively studied and commercially used for improving the blood compatibility of medical devices to reduce thrombosis risk. However, its potential to reduce bacterial adhesion of multiple bacterial species, and overall biofouling on device surfaces, is only now starting to be recognized. This interview with Jeannette Ho, the Head of Surface Modification at Evonik, discusses opportunities for medical device companies to leverage this passive, stable and durable technology platform to reduce bacterial adhesion and biofouling.